These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 15733882)

  • 1. Low-dose secnidazole in the treatment of bacterial vaginosis.
    Núñez JT; Gómez G
    Int J Gynaecol Obstet; 2005 Mar; 88(3):281-5. PubMed ID: 15733882
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A phase-3, double-blind, placebo-controlled study of the effectiveness and safety of single oral doses of secnidazole 2 g for the treatment of women with bacterial vaginosis.
    Schwebke JR; Morgan FG; Koltun W; Nyirjesy P
    Am J Obstet Gynecol; 2017 Dec; 217(6):678.e1-678.e9. PubMed ID: 28867602
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Secnidazole Treatment of Bacterial Vaginosis: A Randomized Controlled Trial.
    Hillier SL; Nyirjesy P; Waldbaum AS; Schwebke JR; Morgan FG; Adetoro NA; Braun CJ
    Obstet Gynecol; 2017 Aug; 130(2):379-386. PubMed ID: 28697102
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Phase 3, Multicenter, Prospective, Open-Label Study to Evaluate the Safety of a Single Dose of Secnidazole 2 g for the Treatment of Women and Postmenarchal Adolescent Girls with Bacterial Vaginosis.
    Chavoustie SE; Gersten JK; Samuel MJ; Schwebke JR
    J Womens Health (Larchmt); 2018 Apr; 27(4):492-497. PubMed ID: 29323627
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Secnidazole for treatment of bacterial vaginosis: a systematic review.
    Abd El Aziz MA; Sharifipour F; Abedi P; Jahanfar S; Judge HM
    BMC Womens Health; 2019 Oct; 19(1):121. PubMed ID: 31638955
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment for Symptomatic Bacterial Vaginosis: ARandomized Controlled Trial.
    Tariq N; Basharat A; Khan DH; Fahim A; Khan MH
    J Coll Physicians Surg Pak; 2017 Nov; 27(11):686-689. PubMed ID: 29132478
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of bacterial vaginosis with oral or vaginal ornidazole, secnidazole and metronidazole.
    Saraçoğlu F; Göl K; Sahin I; Türkkani B; Atalay C; Oztopçu C
    Int J Gynaecol Obstet; 1998 Jul; 62(1):59-61. PubMed ID: 9722127
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of single dose of oral secnidazole 2 g in treatment of bacterial vaginosis: A systematic review and meta-analysis.
    Elghazaly SM; Hamam KM; Badawy MM; Yakoub Agha NA; Samy A; Abbas AM
    Eur J Obstet Gynecol Reprod Biol; 2019 Jul; 238():125-131. PubMed ID: 31129560
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of bacterial vaginosis: a comparison of oral metronidazole, metronidazole vaginal gel, and clindamycin vaginal cream.
    Ferris DG; Litaker MS; Woodward L; Mathis D; Hendrich J
    J Fam Pract; 1995 Nov; 41(5):443-9. PubMed ID: 7595261
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of intravaginal 0.75% metronidazole gel for the treatment of bacterial vaginosis.
    Hillier SL; Lipinski C; Briselden AM; Eschenbach DA
    Obstet Gynecol; 1993 Jun; 81(6):963-7. PubMed ID: 8497364
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of bacterial vaginosis: a multicenter, double-blind, double-dummy, randomised phase III study comparing secnidazole and metronidazole.
    Bohbot JM; Vicaut E; Fagnen D; Brauman M
    Infect Dis Obstet Gynecol; 2010; 2010():. PubMed ID: 20885970
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An Integrated Efficacy and Safety Analysis of Single-Dose Secnidazole 2 g in the Treatment of Bacterial Vaginosis.
    Pentikis H; Adetoro N; Tipping D; Levy S
    Reprod Sci; 2020 Feb; 27(2):523-528. PubMed ID: 32046418
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The association of Atopobium vaginae and Gardnerella vaginalis with bacterial vaginosis and recurrence after oral metronidazole therapy.
    Bradshaw CS; Tabrizi SN; Fairley CK; Morton AN; Rudland E; Garland SM
    J Infect Dis; 2006 Sep; 194(6):828-36. PubMed ID: 16941351
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Secnidazole. A review of its antimicrobial activity, pharmacokinetic properties and therapeutic use in the management of protozoal infections and bacterial vaginosis.
    Gillis JC; Wiseman LR
    Drugs; 1996 Apr; 51(4):621-38. PubMed ID: 8706597
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Efficacy of 5-nitroimidazole derivatives in treatment of bacterial vaginosis].
    Wang FM; Qian XD; Xu H; Yu HY
    Zhonghua Yi Xue Za Zhi; 2008 Aug; 88(31):2201-3. PubMed ID: 19080672
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Secnidazole: next-generation antimicrobial agent for bacterial vaginosis treatment.
    Nyirjesy P; Schwebke JR
    Future Microbiol; 2018 Apr; 13():507-524. PubMed ID: 29327947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the Effect of Vaginal Zataria multiflora Cream and Oral Metronidazole Pill on Results of Treatments for Vaginal Infections including Trichomoniasis and Bacterial Vaginosis in Women of Reproductive Age.
    Abdali K; Jahed L; Amooee S; Zarshenas M; Tabatabaee H; Bekhradi R
    Biomed Res Int; 2015; 2015():683640. PubMed ID: 26266260
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Single-dose versus 7-day-dose metronidazole for the treatment of trichomoniasis in women: an open-label, randomised controlled trial.
    Kissinger P; Muzny CA; Mena LA; Lillis RA; Schwebke JR; Beauchamps L; Taylor SN; Schmidt N; Myers L; Augostini P; Secor WE; Bradic M; Carlton JM; Martin DH
    Lancet Infect Dis; 2018 Nov; 18(11):1251-1259. PubMed ID: 30297322
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparative study of oral single dose of metronidazole, tinidazole, secnidazole and ornidazole in bacterial vaginosis.
    Thulkar J; Kriplani A; Agarwal N
    Indian J Pharmacol; 2012 Mar; 44(2):243-5. PubMed ID: 22529484
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and Safety of Single Oral Dosing of Secnidazole for Trichomoniasis in Women: Results of a Phase 3, Randomized, Double-Blind, Placebo-Controlled, Delayed-Treatment Study.
    Muzny CA; Schwebke JR; Nyirjesy P; Kaufman G; Mena LA; Lazenby GB; Van Gerwen OT; Graves KJ; Arbuckle J; Carter BA; McMahon CP; Eder S; Shaw J; Pandey B; Chavoustie SE
    Clin Infect Dis; 2021 Sep; 73(6):e1282-e1289. PubMed ID: 33768237
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.